Dr. Dhananjay Jere, Lonza Drug Product Services - Qepler Summits And Conferences

Dr. Dhananjay Jere

Senior Principal Scientist, Principal Group Leader
Lonza Drug Product Services
Basel, Switzerland
Lonza’s drug product service specializes in formulation development and analytical development for parenteral dosage forms.

Dr. Jere is working as a Senior Principal Scientist, Principal group leader with Lonza Drug Product Services since 2016.

Prior to joining Lonza, he has worked with Roche in Switzerland and US for 7 years.

Dr. Jere has over 10 years of parenteral drug product development experience in early and late stage, mainly Biologics.

He has supported no. of IND/IMPDs/BAL filings for NBEs. He has also been involved in the development of novel drug delivery systems, Cell and Gene Therapy Products (ATMPs).

Dr. Jere has special expertise in CMC and regulatory requirements for intraocular drug product development and has to his credit over 30 international peered review publications and patents.

Related Sessions:

2nd Annual Pre-Filled
Syringes Summit 2019

Enhance expertise sharing in developing pre-filled syringes and provide attendees with ample networking opportunities.
  • 04 Jun 2019
  • Barcelona, ES
  • Pharma
Day 1: Tuesday, 04 June 2019
CASE STUDY: Challenges for High Concentration Biologics Drug Products at the Interface of Formulation, Primary Packaging and Application.

Talk will focus on integrated development approach of high concentration Drug-Device Combination Products. Importance of formulation and stability, container-closure system and application in product development. Special consideration for intravitreal injection including particulate requirements, syringeability and handling consideration for dosing.

View Details